NYSE:FNA - Post Discussion
Post by
AviseAnalytics on May 08, 2024 9:26am
PARAGON 28: “WALKING” THE ROAD TO PROFITABILITY
$FNA
Excited to share an article about Paragon 28, Inc. (NYSE: FNA), a medical device company exclusively focused on the foot and ankle orthopedic market.
The global market for implants and devices used in foot and ankle procedures is projected to grow at approximately 7% annually to reach $6.9 billion by 2028. The Company has invested heavily in research and innovation - it has more than 30 product and system offerings in its development pipeline. It expects the majority to launch commercially in the next 24 months. Moreover, for FY24, Paragon displayed 19.7% increases in revenues YoY, making the Company an interesting watch.
Read on to know more:
https://www.aviseanalytics.com/paragon-28-walking-the-road-to-profitability/
Be the first to comment on this post